S.252 - Medicare Drug Savings Act of 2017115th Congress (2017-2018)
|Sponsor:||Sen. Nelson, Bill [D-FL] (Introduced 02/01/2017)|
|Committees:||Senate - Finance|
|Latest Action:||Senate - 02/01/2017 Read twice and referred to the Committee on Finance. (All Actions)|
This bill has the status Introduced
Here are the steps for Status of Legislation:
Summary: S.252 — 115th Congress (2017-2018)All Information (Except Text)
Introduced in Senate (02/01/2017)
Medicare Drug Savings Act of 2017
This bill requires drug manufacturers to issue rebates to the Centers for Medicare & Medicaid Services (CMS) for prescription drugs dispensed to eligible low-income individuals under the Medicare prescription drug benefit or a Medicare Advantage (MA) prescription drug plan (PDP).
Subject to civil monetary penalties, a Medicare or MA PDP sponsor must report, both to drug manufacturers and to the CMS, specified information related to the determination and payment of such rebates.